SiRNA-based delivery nanoplatform attenuates the CRC progression via HIF1α-AS2
Qingtao Meng(Wuhan University), Rui Chen(Capital Medical University), Hongbao Yang(China Pharmaceutical University), Jin Xu(Nanjing Medical University), Jie Xu(Hubei University of Medicine), Bo Jiang(Capital Medical University), Xiaobo Li(Shanxi Medical University), Jing Wang(NYU Langone Health), Yu Zhang(Rutherford Appleton Laboratory), Xinwei Zhang(Southeast University), Hanqing Chen(Capital Medical University), Na Gao(University of Chinese Academy of Sciences), Shenshen Wu(China Medical University), Yuanyuan Cao(Capital Medical University)
Cited by 10
Related Papers
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
Quercetin alleviates acute kidney injury by inhibiting ferroptosis
|Journal of Advanced Research|2020|601
Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response
|Proceedings of the National Academy of Sciences|2018|410